13F COMBINATION REPORT
Yu Fan
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000950123-25-005584
Total Value
$97.3M
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KESTRA MED TECHNOLOGIES LTD | BEKE | 2,282,519 | $56.9M | 58.45% |
| 2 | CERIBELL INC | CBLL | 1,222,202 | $23.5M | 24.13% |
| 3 | ALUMIS INC | ALMS | 789,618 | $4.8M | 4.98% |
| 4 | CG ONCOLOGY INC | CGON | 163,456 | $4.0M | 4.11% |
| 5 | CARGO THERAPEUTICS INC | 14179K101 | 912,000 | $3.7M | 3.82% |
| 6 | WHITEHAWK THERAPEUTICS INC | WHWK | 2,070,000 | $3.7M | 3.79% |
| 7 | CASTLE BIOSCIENCES INC | CSTL | 22,503 | $450,510 | 0.46% |
| 8 | SAGIMET BIOSCIENCES INC | SGMT | 57,190 | $186,439 | 0.19% |
| 9 | PYXIS ONCOLOGY INC | PYXS | 69,303 | $67,910 | 0.07% |